Incyte
INCY
#1220
Rank
HK$143.87 B
Marketcap
HK$722.95
Share price
-2.10%
Change (1 day)
50.04%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): HK$47.75

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$47.97. In 2024 the company made an earnings per share (EPS) of HK$2.43 a decrease over its 2023 EPS that were of HK$20.93.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$47.751865.13%
2024HK$2.43-88.39%
2023HK$20.9373.38%
2022HK$12.07-64.1%
2021HK$33.62-408.63%
2020-HK$10.89-166.83%
2019HK$16.30300%
2018HK$4.08-133.33%
2017-HK$12.23-378.57%
2016HK$4.392700%
2015HK$0.16-106.67%
2014-HK$2.35-44.44%
2013-HK$4.2350%
2012-HK$2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$57.69 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.66-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.42 276.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.31 134.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.73-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.94-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.55-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.58-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.80-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA